Related Experiment Videos

Dipyridamole therapy improves long-term survival after complete revascularization in patients with impaired cardiac

Eiji Ikeda1, Takatoshi Kasai, Kan Kajimoto

  • 1Department of Cardiovascular Surgery, Juntendo University, School of Medicine, Tokyo, Japan.

Circulation Journal : Official Journal of the Japanese Circulation Society
|September 2, 2008
PubMed

Insights

Dipyridamole use after complete revascularization significantly lowered long-term all-cause and cardiac mortality in patients with impaired left ventricular (LV) function.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Dipyridamole, previously used for coronary artery disease, is being re-evaluated for its effects on cardiac function.
  • Elevated serum adenosine levels from dipyridamole show promise in improving heart failure outcomes.
  • The coronary steal phenomenon previously limited dipyridamole's use.

Purpose of the Study:

  • To investigate the long-term impact of dipyridamole on mortality in patients with impaired left ventricular (LV) function undergoing complete revascularization.
  • To assess if dipyridamole administration at the time of revascularization influences survival rates.

Main Methods:

  • A cohort of 1,836 patients undergoing complete revascularization was assessed, with 254 patients having impaired LV function (ejection fraction < 50%) enrolled.
  • Cox proportional hazards regression and propensity score analysis were employed to compare mortality risks.
  • Follow-up extended to a mean of 12 years.

Main Results:

  • 178 patients (70.1%) received dipyridamole.
  • The dipyridamole group exhibited a significantly lower risk of all-cause mortality (HR 0.54; p = 0.005).
  • Cardiac mortality was also substantially reduced in the dipyridamole group (HR 0.42; p = 0.010).

Conclusions:

  • Dipyridamole use is associated with reduced all-cause mortality in patients with impaired LV function post-revascularization.
  • Dipyridamole administration significantly decreases cardiac mortality in this patient population.
  • These findings suggest a potential benefit of dipyridamole in managing patients with compromised left ventricular function.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...